Location History:
- Palo Alto, CA (US) (2005 - 2007)
- Menlo Park, CA (US) (2009 - 2012)
Company Filing History:
Years Active: 2005-2012
Title: The Innovative Contributions of Jay Wohlgemuth
Introduction
Jay Wohlgemuth is a prominent inventor based in Menlo Park, California. He has made significant contributions to the field of diagnostics, particularly in autoimmune and chronic inflammatory diseases. With a total of 14 patents to his name, Wohlgemuth's work has had a profound impact on medical diagnostics.
Latest Patents
Wohlgemuth's latest patents include methods and compositions for diagnosing or monitoring autoimmune and chronic inflammatory diseases. One notable patent describes methods for diagnosing or monitoring systemic lupus erythematosus (SLE) in patients by detecting the expression level of specific genes or their surrogates. Additionally, he has developed diagnostic oligonucleotides for SLE and related kits or systems. Another significant patent focuses on methods for diagnosing or monitoring transplant rejection and cytomegalovirus infection, utilizing similar gene expression detection techniques.
Career Highlights
Throughout his career, Jay Wohlgemuth has worked with several companies, including XDX, Inc. and Expression Diagnostics, Inc. His expertise in diagnostics has positioned him as a key figure in the development of innovative medical technologies.
Collaborations
Wohlgemuth has collaborated with notable professionals in his field, including Kirk E. Fry and Robert Woodward. These collaborations have further enhanced his contributions to medical diagnostics.
Conclusion
Jay Wohlgemuth's innovative work in diagnostics has led to significant advancements in the understanding and monitoring of autoimmune diseases and transplant rejection. His contributions continue to influence the medical field and improve patient outcomes.